{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-110344","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.884393+00:00","generated_at":"2026-05-16T21:37:13.190937+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Journey Medical Q3 2025 revenue $17.6M (+21% YoY); Emrosi sales $4.9M, prescriptions up 146%","bullets":["Q3 2025 net revenues $17.6M, up 21% YoY from $14.6M; driven by Emrosi launch.","Emrosi net sales $4.9M; prescriptions increased 146% sequentially vs Q2 2025.","Net loss narrowed to $2.3M ($0.09/sh) from $2.4M ($0.12/sh) in Q3 2024.","Adjusted EBITDA improved to positive $1.7M vs $0.3M in prior-year quarter.","Gross margin 67.4% vs 69.4% in Q3 2024 (prior year benefited from one-time adjustments)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-110344","json":"https://secwatch.observer/filing/0001104659-25-110344.json","markdown":"https://secwatch.observer/filing/0001104659-25-110344.md","text":"https://secwatch.observer/filing/0001104659-25-110344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925110344/0001104659-25-110344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925110344/tm2530914d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:37:13.190937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}